Immutep Limited Stock Nasdaq
Stocks
IMMP
US45257L1089
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
23:00:00 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.3829 USD | +3.15% |
|
+0.76% | -86.61% |
| 08-31 | Immutep Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| Market Cap | 72.21M 51.79M 44.68M 42.09M 38.35M 71.67M 4.89B 498M 193M 2.5B 194M 190M 8.22B | P/E 2027 * |
-2.45x | P/E 2028 * | -3.41x |
|---|---|---|---|---|---|
| Enterprise Value | 38.1M 27.33M 23.57M 22.21M 20.23M 37.82M 2.58B 263M 102M 1.32B 103M 100M 4.34B | EV / Sales 2027 * |
18.5x | EV / Sales 2028 * | 12.6x |
| Free-Float |
96.98% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +3.15% | ||
| 1 week | +0.76% | ||
| Current month | +4.62% | ||
| 1 month | +0.24% | ||
| 3 months | -7.96% | ||
| 6 months | -85.66% | ||
| Current year | -86.61% |
| 1 week | 0.36 |  | 0.39 |
| 1 month | 0.36 | | 0.41 |
| Current year | 0.29 | | 3.23 |
| 1 year | 0.29 | | 3.53 |
| 3 years | 0.29 | | 3.53 |
| 5 years | 0.29 | | 5 |
| 10 years | 0.29 | | 7.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 53 | 09/07/2014 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/2018 |
Stephan Winckels
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Voigt
BRD | Director/Board Member | 53 | 09/07/2014 |
Russell Howard
CHM | Chairman | 76 | 17/11/2017 |
Pete Meyers
BRD | Director/Board Member | 57 | 12/02/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.15% | +0.76% | - | - | 53.78M | |
| +0.97% | -1.75% | +2.17% | +18.46% | 49.74B | |
| -0.30% | -2.88% | +429.29% | +496.95% | 44.98B | |
| +2.13% | +0.89% | +43.59% | +17.61% | 42.52B | |
| +0.87% | -3.73% | +8.96% | +73.17% | 40.78B | |
| -0.90% | -1.74% | +15.20% | +48.44% | 32.89B | |
| +2.71% | +6.82% | - | - | 17.09B | |
| +1.68% | -4.20% | +25.28% | +116.83% | 16.28B | |
| +1.70% | -0.05% | +18.53% | +28.50% | 14.4B | |
| +3.34% | -1.13% | +80.94% | +39.19% | 13.48B | |
| Average | +1.53% | -1.26% | +78.00% | +104.89% | 30.24B | |
| Weighted average by Cap. | +1.01% | -1.78% | +93.73% | +123.25% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.06M 1.47M 1.27M 1.2M 1.09M 2.04M 139M 14.19M 5.51M 71.23M 5.54M 5.42M 234M | 1.56M 1.12M 963K 907K 827K 1.55M 105M 10.74M 4.17M 53.91M 4.19M 4.1M 177M |
| Net income | -26.64M -19.11M -16.48M -15.53M -14.15M -26.44M -1.8B -184M -71.34M -923M -71.74M -70.17M -3.03B | -32.58M -23.37M -20.16M -18.99M -17.3M -32.34M -2.21B -225M -87.25M -1.13B -87.74M -85.82M -3.71B |
| Net Debt | -34.11M -24.46M -21.1M -19.88M -18.11M -33.86M -2.31B -235M -91.34M -1.18B -91.86M -89.85M -3.88B | -52.61M -37.73M -32.55M -30.66M -27.93M -52.21M -3.56B -363M -141M -1.82B -142M -139M -5.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | $0.3829 | +3.15% | 115,763 |
| 01/09/26 | $0.3712 | +1.42% | 100,557 |
| 31/08/26 | $0.3660 | -3.94% | 177,130 |
| 28/08/26 | $0.3810 | +0.05% | 181,851 |
| 27/08/26 | $0.3808 | +0.21% | 130,661 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
Select your edition
All financial news and data tailored to specific country editions
